Recombinant
RabMAb

Anti-CrkL (phospho Y207) antibody [EP270Y] (ab52908)

Publishing research using ab52908? Please let us know so that we can cite the reference in this datasheet.

ab52908 has been referenced in 6 publications.

  • Ouellette SB  et al. A Cell-Based Assay for Measuring Endogenous BcrAbl Kinase Activity and Inhibitor Resistance. PLoS One 11:e0161748 (2016). PubMed: 27598410
  • Li J  et al. Inhibition of 32Dp210 cells harboring T315I mutation by a novel derivative of emodin correlates with down-regulation of BCR-ABL and its downstream signaling pathways. J Cancer Res Clin Oncol N/A:N/A (2014). Human . PubMed: 25217883
  • Frietsch JJ  et al. LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia. Oncotarget 5:5257-71 (2014). WB . PubMed: 24913448
  • Yang TY  et al. A multiple reaction monitoring (MRM) method to detect Bcr-Abl kinase activity in CML using a peptide biosensor. PLoS One 8:e56627 (2013). WB ; Human . PubMed: 23437189
  • Borgo C  et al. Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: biochemical evidence and therapeutic perspectives. Mol Oncol 7:1103-15 (2013). PubMed: 24012109
  • Placzek EA  et al. A peptide biosensor for detecting intracellular Abl kinase activity using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Biochem 397:73-8 (2010). WB ; Human . PubMed: 19818327

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up